Ergebnisse einer empirischen Untersuchung zur Nutzenermittlung von IT-Investitionen [PDF]
Kesten, Ralf +2 more
core
[Cost aspects and reimbursement requirements of phage therapy]. [PDF]
Häckl D, Dillschneider J, Elsner C.
europepmc +1 more source
[Development, Evaluation and Implementation of Digital Health Interventions (Part 1) - Discussion Paper of the Digital Health Working Group of the German Network for Health Services Research (DNVF)]. [PDF]
Kernebeck S +8 more
europepmc +1 more source
[DemStepCare: Risk-stratified support for primary care-based dementia care - evaluation from general practitioner's view]. [PDF]
Geschke K +7 more
europepmc +1 more source
[More pragmatic randomized studies with a focus on registry-based trials]. [PDF]
Lange S, Lauterberg J.
europepmc +1 more source
[Vaccination: prevention of infectious diseases and their sequelae]. [PDF]
Mylius M, Kuhn J.
europepmc +1 more source
[Patient-reported outcomes-the role of the patient's subjective perspective for research and clinical care]. [PDF]
Dinkel A, Jahnen M.
europepmc +1 more source
A Pharmaceutical Innovation – Is it Worth the Money? Whose Money? [PDF]
This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance.
Michele Sennhauser, Peter Zweifel
core
[Translational challenges and clinical potential of artificial intelligence in minimally invasive surgery]. [PDF]
Carstens M +5 more
europepmc +1 more source

